181 related articles for article (PubMed ID: 37154933)
1. Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.
Kawasaki Y; Hijioka S; Nagashio Y; Maruki Y; Ohba A; Takeshita K; Takasaki T; Agarie D; Hagiwara Y; Hara H; Okamoto K; Yamashige D; Kondo S; Morizane C; Ueno H; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Tamada K; Hiraoka N; Saito Y; Okusaka T
J Gastroenterol; 2023 Jul; 58(7):693-703. PubMed ID: 37154933
[TBL] [Abstract][Full Text] [Related]
2. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
[TBL] [Abstract][Full Text] [Related]
4. Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors.
Crinò SF; Ammendola S; Meneghetti A; Bernardoni L; Conti Bellocchi MC; Gabbrielli A; Landoni L; Paiella S; Pin F; Parisi A; Mastrosimini MG; Amodio A; Frulloni L; Facciorusso A; Larghi A; Manfrin E
Pancreatology; 2021 Mar; 21(2):443-450. PubMed ID: 33390343
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic ultrasound-guided tissue acquisition with or without rapid on-site evaluation for solid pancreatic lesions: five years of experience from a single center.
Liu Y; Xiong D; Zhao Y; Meng Z; Wu X; Jiang Q; Wang Q; Wu D; Zhang S; Feng Y; Yang A
Scand J Gastroenterol; 2023; 58(10):1185-1193. PubMed ID: 37114616
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Neuroendocrine Tumours: The Role of Endoscopic Ultrasound Biopsy in Diagnosis and Grading Based on the WHO 2017 Classification.
Di Leo M; Poliani L; Rahal D; Auriemma F; Anderloni A; Ridolfi C; Spaggiari P; Capretti G; Di Tommaso L; Preatoni P; Zerbi A; Carnaghi C; Lania A; Malesci A; Repici A; Carrara S
Dig Dis; 2019; 37(4):325-333. PubMed ID: 30897588
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.
Hasegawa T; Yamao K; Hijioka S; Bhatia V; Mizuno N; Hara K; Imaoka H; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Kinoshita T; Kohsaki T; Nishimori I; Iwasaki S; Saibara T; Hosoda W; Yatabe Y
Endoscopy; 2014 Jan; 46(1):32-8. PubMed ID: 24218309
[TBL] [Abstract][Full Text] [Related]
8. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up.
Ridtitid W; Halawi H; DeWitt JM; Sherman S; LeBlanc J; McHenry L; Coté GA; Al-Haddad MA
Endoscopy; 2015 Jul; 47(7):617-25. PubMed ID: 25763832
[TBL] [Abstract][Full Text] [Related]
9. EUS-guided fine needle tattooing (EUS-FNT) for preoperative localization of small pancreatic neuroendocrine tumors (p-NETs): a single-center experience.
Rosa F; Rimbaș M; Rizzatti G; Quero G; Fiorillo C; Impagnatiello M; D'Aversa F; Costamagna G; Alfieri S; Larghi A
Surg Endosc; 2021 Jan; 35(1):486-492. PubMed ID: 32959183
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Differentiation of Pancreatic Neuroendocrine Tumor From Other Neoplastic Solid Pancreatic Lesions During Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
Krishna SG; Bhattacharya A; Li F; Ross WA; Ladha H; Porter K; Atiq M; Bhutani MS; Lee JH
Pancreas; 2016 Mar; 45(3):394-400. PubMed ID: 26418912
[TBL] [Abstract][Full Text] [Related]
11. Long-term Follow-up of Small Nonfunctioning Pancreatic Neuroendocrine Tumors Diagnosed Using Endoscopic Ultrasound-guided Fine-needle Aspiration.
Takano Y; Yamawaki M; Noda J; Azami T; Niiya F; Maruoka N; Yamagami T; Norose T; Ohike N; Nagahama M
Intern Med; 2023 Dec; 62(24):3585-3590. PubMed ID: 37081682
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysis.
Sirtl S; Mahajan UM; Auernhammer CJ; Dziadkiewicz P; Hohmann E; Wójcik M; Kos-Kudła B; Hartleb M; Knösel T; Schirra J; Mayerle J; Schulz C; Żorniak M
Pancreatology; 2022 Jun; 22(5):644-650. PubMed ID: 35589512
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of adverse events associated with endoscopic ultrasound-guided fine needle aspiration of pancreatic solid lesions.
Katanuma A; Maguchi H; Yane K; Hashigo S; Kin T; Kaneko M; Kato S; Kato R; Harada R; Osanai M; Takahashi K; Nojima M
Dig Dis Sci; 2013 Jul; 58(7):2093-9. PubMed ID: 23423501
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic Ultrasound-Guided Therapies in Patients with Pancreatic Neuroendocrine Tumors.
Morgan AD; Ramai D; Bandaru P; Crino SF; Facciorusso A
Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1355-1358. PubMed ID: 37055906
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of solid-pseudopapillary tumors of the pancreas from pancreatic neuroendocrine tumors by using endoscopic ultrasound.
Liu Y; Shi S; Hua J; Xu J; Zhang B; Liu J; Yang XJ; Yu XJ
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):947-953. PubMed ID: 32144073
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and predictive factors of endoscopic ultrasound-guided ethanol ablation in benign solid pancreatic tumors.
Choi JH; Paik WH; Lee SH; Lee MW; Cho IR; Ryu JK; Kim YT
Surg Endosc; 2023 Aug; 37(8):5960-5968. PubMed ID: 37079095
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of endoscopic ultrasound-guided tissue acquisition by EUS-FNA versus EUS-FNB for solid pancreatic mass without ROSE: a retrospective study.
Wong T; Pattarapuntakul T; Netinatsunton N; Ovartlarnporn B; Sottisuporn J; Chamroonkul N; Sripongpun P; Jandee S; Kaewdech A; Attasaranya S; Piratvisuth T
World J Surg Oncol; 2022 Jun; 20(1):215. PubMed ID: 35751053
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of performing endoscopic ultrasound-guided fine-needle biopsy for pancreatic neuroendocrine tumors less than 2 cm.
Heidsma CM; Tsilimigras DI; Rocha F; Abbott DE; Fields R; Smith PM; Poultsides GA; Cho C; van Eijck C; van Dijkum EN; Maithel SK; Pawlik TM;
J Surg Oncol; 2020 Dec; 122(7):1393-1400. PubMed ID: 32783272
[TBL] [Abstract][Full Text] [Related]
20. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
Krishna SG; Bhattacharya A; Ross WA; Ladha H; Porter K; Bhutani MS; Lee JH
J Gastroenterol Hepatol; 2015 Oct; 30(10):1552-60. PubMed ID: 25867963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
